Exploring the potential of a bridge therapy: Synergistic approach integrating intravenous ketamine and intranasal esketamine for <scp>treatment‐resistant</scp> depression-Reference-Cited by-同舟云学术

Exploring the potential of a bridge therapy: Synergistic approach integrating intravenous ketamine and intranasal esketamine for treatment‐resistant depression

Published:2023-09-08 Issue:4 Volume:148 Page:385-387
ISSN:0001-690X
Container-title:Acta Psychiatrica Scandinavica
language:en
Short-container-title:Acta Psychiatr Scand

Author:

d'Andrea Giacomo¹^ORCID,Pettorruso Mauro¹^ORCID,Rhee Taeho Greg²³⁴,Di Lorenzo Giorgio⁵⁶^ORCID,McIntyre Roger S.⁷⁸⁹¹⁰¹¹^ORCID,Martinotti Giovanni¹¹²^ORCID

Affiliation:

1. Department of Neurosciences, Imaging and Clinical Sciences University “G. D'Annunzio” Chieti Italy

2. Department of Psychiatry Yale School of Medicine New Haven Connecticut USA

3. VA New England Mental Illness, Research, Education and Clinical Center (MIRECC) VA Connecticut Healthcare System West Haven Connecticut USA

4. Department of Public Health Sciences, School of Medicine University of Connecticut Farmington Connecticut USA

5. Chair of Psychiatry, Department of Systems Medicine University of Rome Tor Vergata Rome Italy

6. IRCCS Fondazione Santa Lucia Rome Italy

7. Department of Pharmacology and Toxicology University of Toronto Toronto Ontario Canada

8. Mood Disorders Psychopharmacology Unit University Health Network Toronto Ontario Canada

9. Department of Psychiatry University of Toronto Toronto Ontario Canada

10. Braxia Health Canadian Centre for Rapid Treatment Excellence (CRTCE) Mississauga Ontario Canada

11. Brain and Cognition Discovery Foundation Toronto Ontario Canada

12. Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences University of Hertfordshire Hatfield UK

Publisher

Wiley

Subject

Psychiatry and Mental health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/acps.13605

Reference6 articles.

1. Treatment-resistant depression: Definitions, review of the evidence, and algorithmic approach

2. Rethinking ketamine and esketamine action: Are they antidepressants with mood-stabilizing properties?

3. The effectiveness of repeated intravenous ketamine on depressive symptoms, suicidal ideation and functional disability in adults with major depressive disorder and bipolar disorder: Results from the Canadian Rapid Treatment Center of Excellence

4. Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation

5. Real-world experience of esketamine use to manage treatment-resistant depression: A multicentric study on safety and effectiveness (REAL-ESK study)

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intravenous (IV) ketamine versus intranasal esketamine for depression– Advantage IV ketamine?;Journal of Affective Disorders;2024-07

2. The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data;Journal of Affective Disorders;2024-03

3. Use of ketamine for treatment resistant depression: updated review of literature and practical applications to a community ketamine program in Edmonton, Alberta, Canada;Frontiers in Psychiatry;2024-01-08

4. The not so little matter of how to dose ketamine in patients with depression;Acta Psychiatrica Scandinavica;2023-09-17